PO-1182: PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []